Skip to content

Acute Myeloid Leukemia T 11 15 P15 Q35 Cn305565

Published: July 22, 2026Updated: August 20, 2026

An aggressive blood cancer starting in bone marrow where immature white blood cells multiply abnormally. It disrupts normal blood cell production and most often affects adults. Treatment typically involves intensive chemotherapy and may require transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Easy bruising

(hematologic)

Shortness of breath

(respiratory)

Swollen lymph nodes

(lymphatic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

HOVON-SAKK Regimen

Intensive chemotherapy protocol tailored for AML with chromosomal abnormalities including t(11;15), combining multiple agents to maximize antileukemic effect.

medication
3

Matched Sibling Donor Transplant

Allogeneic transplantation using stem cells from an HLA-matched sibling donor, offering potentially curative option through graft-versus-leukemia effect.

procedure

Additional treatment options

Venetoclax-Based Regimen

Bcl-2 inhibitor venetoclax combined with hypomethylating agents or low-dose cytarabine, representing a chemotherapy-free option for ineligible patients.

medication

Molecular Response Surveillance

Regular molecular monitoring using PCR or NGS techniques to track disease burden and detect molecular recurrence before clinical relapse occurs.

monitoring

Physical Activity Program

Supervised exercise program designed to maintain physical function, reduce fatigue, and improve quality of life during and after AML treatment.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia T 11 15 P15 Q35 Cn305565?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017.

guideline2017
2

Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013.

clinical_trial2013
3

Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009.

review2009
4

Wang H, Chen Y, Liu Y, et al. All-trans retinoic acid-based combination therapy for acute promyelocytic leukemia: a systematic review and meta-analysis. Haematologica. 2018.

meta_analysis2018

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia T 11 15 P15 Q35 Cn305565. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy